Secure, Confidential Technical Exchange
Mutual Non-Disclosure Agreement (mNDA) Request
At Elixis Biosciences LLC, we recognize that the foundation of any successful strategic advisory or formulation partnership is the absolute protection of intellectual property. We require a Mutual Non-Disclosure Agreement (mNDA) to be fully executed prior to the exchange of any proprietary data, unpublished formulations, or confidential business strategies.
Our standard mNDA provides a reciprocal, legally binding framework designed to protect the trade secrets and confidential information of both your organization and Elixis Biosciences, allowing for a transparent and rigorous technical evaluation.
The Execution Process
01
Submit Request
Complete the intake form below with your organization's legal details and the designated authorized signatory.
02
Document Generation
Upon receipt, our team will generate a customized mNDA and route it to your authorized signatory via secure electronic signature.
03
Countersignature & Clearance
Once signed by your organization, Elixis Biosciences will countersign and provide a fully executed PDF for your corporate records.
04
Technical Discovery
With the NDA in place, we will schedule a secure consultation to discuss your formulation architecture, tech transfer, or evaluation requirements in depth.
For questions regarding this process, or if your organization requires the use of a custom NDA template provided by your legal counsel, please contact inquiries@elixisbio.com directly.